Expomed Eurasia 2026 in Istanbul: Aliko Scientific focuses on new distribution partnerships

Following the strong momentum generated during WHX Labs Dubai 2026, Aliko Scientific continues its international expansion strategy by strengthening its presence in key high-growth markets, with a particular focus on Turkey and the broader Eurasian region.

From April 16 to 18, 2026, Aliko Scientific will participate in Expomed Eurasia in Istanbul, one of the leading medical trade fairs connecting Europe, Asia, and the Middle East. This event represents a strategic opportunity to further develop our global distribution network and establish new partnerships with qualified players in the field of anatomical pathology and cancer diagnostics.

Our participation in Expomed is part of a broader initiative aimed at identifying and engaging new distributors and commercial partners, in line with the Group’s mission to expand access to advanced cancer diagnostic technologies worldwide. Building on the success and high-quality meetings held in Dubai, we are continuing to meet selected companies interested in integrating innovative solutions in cytology and molecular diagnostics into their portfolios.

During the exhibition, Aliko Scientific will be hosted within the ICE Agency (Italian Trade Agency) pavilion, at: Hall 8 – Stand 8/840D

This presence reinforces our positioning as a representative of Italian excellence in medical technology and diagnostics, while benefiting from the strong international visibility of the Italian collective pavilion.

Visitors will have the opportunity to discover our integrated diagnostic solutions, combining cytology, molecular analysis, and automation to improve efficiency, accuracy, and scalability in laboratory workflows. These solutions reflect the Group’s vision of creating a fully integrated diagnostic ecosystem, from sample preparation to advanced analysis, supporting early cancer detection and better patient outcomes.